This bioproduction tools provider for cell and gene therapy reported a notable insider sale.
This bioproduction tools provider for cell and gene therapy reported a notable insider sale amid a modestly downtrending share price.
Troy Wichterman, Chief …
BioLife Solutions’ CFO Sells 30,000 Shares
Recent Comments